Search Reports
Categories
Categories

Global Polio Vaccine Market

Global Polio Vaccine Market Research Report 2024(Status and Outlook)

Report Code : PHA1627
Published Date : 05 December, 2024 | No of Pages: 139

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Polio vaccine is a critical immunization tool in the global fight against poliomyelitis, a highly infectious viral disease that primarily affects young children. The vaccine works by stimulating the immune system to produce antibodies against the poliovirus, providing immunity to the disease. Positioned within the broader pharmaceutical and healthcare sector, the polio vaccine market plays a pivotal role in public health initiatives worldwide.

As of 2023, the global polio vaccine market size stands at approximately USD 900 million. Looking ahead, the market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.67% from 2024 to 2032. This growth can be attributed to several key drivers and market forces. Firstly, increasing government initiatives and funding for immunization programs, especially in developing countries, are boosting the demand for polio vaccines. Additionally, rising awareness about the importance of vaccination in preventing infectious diseases is driving market growth. Moreover, technological advancements in vaccine development and distribution are further propelling market expansion.

Analyzing current market trends reveals several noteworthy developments. One prominent trend is the growing emphasis on universal immunization programs, aiming to reach every child with essential vaccines, including polio vaccines. This trend is supported by initiatives such as the Global Polio Eradication Initiative, which has significantly contributed to reducing polio cases globally. Furthermore, the shift towards combination vaccines, where multiple vaccines are administered in a single shot, is gaining traction due to its convenience and cost-effectiveness.

In terms of regional market distribution, certain regions stand out as leading markets for polio vaccines. North America and Europe hold significant market shares, driven by robust healthcare infrastructure, high awareness levels, and government support for vaccination programs. In contrast, regions like Asia Pacific and Africa present immense growth opportunities due to large population sizes, increasing healthcare investments, and rising disease burden. Factors such as government policies, disease prevalence, and socio-economic conditions play crucial roles in shaping regional market dynamics.

Despite the positive market outlook, the polio vaccine market faces some key challenges. One such challenge is vaccine hesitancy, fueled by misinformation and lack of trust in vaccines. Addressing this challenge requires targeted communication strategies and community engagement efforts to build trust and confidence in vaccination programs. Additionally, logistical hurdles in vaccine distribution, especially in remote or conflict-affected areas, pose challenges to reaching vulnerable populations.

In conclusion, the polio vaccine market is poised for steady growth driven by increasing immunization efforts, technological advancements, and rising awareness about the importance of vaccination. To capitalize on market opportunities, stakeholders should focus on expanding access to vaccines, addressing vaccine hesitancy, and strengthening healthcare infrastructure in key regions. By navigating these challenges effectively, the market can continue to play a vital role in safeguarding public health and advancing global immunization efforts.
This report provides a deep insight into the global Polio Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Polio Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Polio Vaccine market in any manner.
Global Polio Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Market Segmentation (by Application)
Public
Private

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Polio Vaccine Market
• Overview of the regional outlook of the Polio Vaccine Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Polio Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Polio Vaccine
      1.2 Key Market Segments
            1.2.1 Polio Vaccine Segment by Type
            1.2.2 Polio Vaccine Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Polio Vaccine Market Overview
      2.1 Global Market Overview
            2.1.1 Global Polio Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
            2.1.2 Global Polio Vaccine Sales Estimates and Forecasts (2019-2032)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
      2.4 Macroeconomic Analysis
  3 Polio Vaccine Market Competitive Landscape
      3.1 Global Polio Vaccine Sales by Manufacturers (2019-2024)
      3.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
      3.3 Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.4 Global Polio Vaccine Average Price by Manufacturers (2019-2024)
      3.5 Manufacturers Polio Vaccine Sales Sites, Area Served, Product Type
      3.6 Polio Vaccine Market Competitive Situation and Trends
            3.6.1 Polio Vaccine Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Polio Vaccine Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Polio Vaccine Industry Chain Analysis
      4.1 Polio Vaccine Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Polio Vaccine Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Market Restraints
      5.5 Industry News
            5.5.1 New Product Developments
            5.5.2 Mergers & Acquisitions
            5.5.3 Expansions
            5.5.4 Collaboration/Supply Contracts
      5.6 Industry Policies
  6 Polio Vaccine Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Polio Vaccine Sales Market Share by Type (2019-2024)
      6.3 Global Polio Vaccine Market Size Market Share by Type (2019-2024)
      6.4 Global Polio Vaccine Price by Type (2019-2024)
  7 Polio Vaccine Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Polio Vaccine Market Sales by Application (2019-2024)
      7.3 Global Polio Vaccine Market Size (M USD) by Application (2019-2024)
      7.4 Global Polio Vaccine Sales Growth Rate by Application (2019-2024)
  8 Polio Vaccine Market Sales by Region
      8.1 Global Polio Vaccine Sales by Region
            8.1.1 Global Polio Vaccine Sales by Region
            8.1.2 Global Polio Vaccine Sales Market Share by Region
      8.2 Global Polio Vaccine Market Size by Region
            8.2.1 Global Polio Vaccine Market Size by Region
            8.2.2 Global Polio Vaccine Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Polio Vaccine Sales by Country
            8.3.2 North America Polio Vaccine Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Polio Vaccine Sales by Country
            8.4.2 Europe Polio Vaccine Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Russia Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Polio Vaccine Sales by Region
            8.5.2 China
            8.5.3 Japan
            8.5.4 South Korea
            8.5.5 India
            8.5.6 Southeast Asia
      8.6 Asia Pacific
            8.6.1 Asia Pacific Polio Vaccine Market Size by Region
            8.6.2 Asia Pacific Polio Vaccine Market Size by Region
            8.6.3 China
            8.6.4 Japan
            8.6.5 South Korea
            8.6.6 India
            8.6.7 Southeast Asia
      8.7 South America
            8.7.1 South America Polio Vaccine Sales by Country
            8.7.2 South America Polio Vaccine Market Size by Country
            8.7.3 Brazil
            8.7.4 Argentina
            8.7.5 Columbia
      8.8 Middle East and Africa
            8.8.1 Middle East and Africa Polio Vaccine Sales by Region
            8.8.2 Middle East and Africa Polio Vaccine Market Size by Region
            8.8.3 Saudi Arabia
            8.8.4 UAE
            8.8.5 Egypt
            8.8.6 Nigeria
            8.8.7 South Africa
  9 Polio Vaccine Market Production by Region
      9.1 Global Production of Polio Vaccine by Region (2019-2024)
      9.2 Global Polio Vaccine Revenue Market Share by Region (2019-2024)
      9.3 Global Polio Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
      9.4 North America Polio Vaccine Production
            9.4.1 North America Polio Vaccine Production Growth Rate (2019-2024)
            9.4.2 North America Polio Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
      9.5 Europe Polio Vaccine Production
            9.5.1 Europe Polio Vaccine Production Growth Rate (2019-2024)
            9.5.2 Europe Polio Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
      9.6 Japan Polio Vaccine Production (2019-2024)
            9.6.1 Japan Polio Vaccine Production Growth Rate (2019-2024)
            9.6.2 Japan Polio Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
      9.7 China Polio Vaccine Production (2019-2024)
            9.7.1 China Polio Vaccine Production Growth Rate (2019-2024)
            9.7.2 China Polio Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
  10 Key Companies Profile
      10.1 Sanofi
            10.1.1 Sanofi Polio Vaccine Basic Information
            10.1.2 Sanofi Polio Vaccine Product Overview
            10.1.3 Sanofi Polio Vaccine Product Market Performance
            10.1.4 Sanofi Business Overview
            10.1.5 Sanofi Polio Vaccine SWOT Analysis
            10.1.6 Sanofi Recent Developments
      10.2 GSK
            10.2.1 GSK Polio Vaccine Basic Information
            10.2.2 GSK Polio Vaccine Product Overview
            10.2.3 GSK Polio Vaccine Product Market Performance
            10.2.4 GSK Business Overview
            10.2.5 GSK Polio Vaccine SWOT Analysis
            10.2.6 GSK Recent Developments
      10.3 Bibcol
            10.3.1 Bibcol Polio Vaccine Basic Information
            10.3.2 Bibcol Polio Vaccine Product Overview
            10.3.3 Bibcol Polio Vaccine Product Market Performance
            10.3.4 Bibcol Polio Vaccine SWOT Analysis
            10.3.5 Bibcol Business Overview
            10.3.6 Bibcol Recent Developments
      10.4 Serum Institute
            10.4.1 Serum Institute Polio Vaccine Basic Information
            10.4.2 Serum Institute Polio Vaccine Product Overview
            10.4.3 Serum Institute Polio Vaccine Product Market Performance
            10.4.4 Serum Institute Business Overview
            10.4.5 Serum Institute Recent Developments
      10.5 Tiantan Biological
            10.5.1 Tiantan Biological Polio Vaccine Basic Information
            10.5.2 Tiantan Biological Polio Vaccine Product Overview
            10.5.3 Tiantan Biological Polio Vaccine Product Market Performance
            10.5.4 Tiantan Biological Business Overview
            10.5.5 Tiantan Biological Recent Developments
      10.6 IMBCA
            10.6.1 IMBCA Polio Vaccine Basic Information
            10.6.2 IMBCA Polio Vaccine Product Overview
            10.6.3 IMBCA Polio Vaccine Product Market Performance
            10.6.4 IMBCA Business Overview
            10.6.5 IMBCA Recent Developments
      10.7 Panacea Biotec Ltd
            10.7.1 Panacea Biotec Ltd Polio Vaccine Basic Information
            10.7.2 Panacea Biotec Ltd Polio Vaccine Product Overview
            10.7.3 Panacea Biotec Ltd Polio Vaccine Product Market Performance
            10.7.4 Panacea Biotec Ltd Business Overview
            10.7.5 Panacea Biotec Ltd Recent Developments
      10.8 Bio-Med
            10.8.1 Bio-Med Polio Vaccine Basic Information
            10.8.2 Bio-Med Polio Vaccine Product Overview
            10.8.3 Bio-Med Polio Vaccine Product Market Performance
            10.8.4 Bio-Med Business Overview
            10.8.5 Bio-Med Recent Developments
      10.9 Halfkin Bio-Pharmaceuticals
            10.9.1 Halfkin Bio-Pharmaceuticals Polio Vaccine Basic Information
            10.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Overview
            10.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Market Performance
            10.9.4 Halfkin Bio-Pharmaceuticals Business Overview
            10.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
  11 Polio Vaccine Market Forecast by Region
      11.1 Global Polio Vaccine Market Size Forecast
      11.2 Global Polio Vaccine Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Polio Vaccine Market Size Forecast by Country
            11.2.3 Asia Pacific Polio Vaccine Market Size Forecast by Region
            11.2.4 South America Polio Vaccine Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Polio Vaccine by Country
  12 Forecast Market by Type and by Application (2025-2032)
      12.1 Global Polio Vaccine Market Forecast by Type (2025-2032)
            12.1.1 Global Forecasted Sales of Polio Vaccine by Type (2025-2032)
            12.1.2 Global Polio Vaccine Market Size Forecast by Type (2025-2032)
            12.1.3 Global Forecasted Price of Polio Vaccine by Type (2025-2032)
      12.2 Global Polio Vaccine Market Forecast by Application (2025-2032)
            12.2.1 Global Polio Vaccine Sales (K MT) Forecast by Application
            12.2.2 Global Polio Vaccine Market Size (M USD) Forecast by Application (2025-2032)
  13 Conclusion and Key Findings
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Please select License
Single User Price:$ 2800
Site License Price:$ 3600
Enterprise Price:$ 3600